Success Metrics

Active Trials
1(100%)

Phase Distribution

Ph phase_2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
recruitingphase_2

RC48 in Combination With AK104 and Bevacizumab in OCCC

NCT06540729

Clinical Trials (1)

Showing 1 of 1 trials
NCT06540729Phase 2

RC48 in Combination With AK104 and Bevacizumab in OCCC

Recruiting

All 1 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
1